Cheshire, CT, United States of America

Siguang Sui

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Cheshire, CT (US) (2022)
  • South Glastonbury, CT (US) (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Siguang Sui

Introduction

Siguang Sui is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of biochemistry, particularly in the production of recombinant proteins. With a total of 2 patents, Sui's work has advanced the methods used in pharmaceutical manufacturing.

Latest Patents

Sui's latest patents include a method for producing recombinant alkaline phosphatase. This method involves controlling production parameters, particularly the harvest clarified culture fluid (HCCF) and filtration pool (UFDF), to achieve a defined total sialic acid content. Another significant patent is focused on the manufacturing of alkaline phosphatases. This method outlines the use of a fed-batch bioreactor, where cells capable of expressing the recombinant polypeptide asfotase alfa are cultured under specific conditions to optimize production.

Career Highlights

Siguang Sui is currently employed at Alexion Pharmaceuticals, Inc., where he continues to innovate in the field of recombinant protein production. His expertise in biochemistry and protein engineering has positioned him as a valuable asset to his team and the company.

Collaborations

Sui collaborates with talented professionals such as Rahul Godawat and Meghan Dewitt. Their combined efforts contribute to the advancement of biopharmaceutical technologies.

Conclusion

Siguang Sui's contributions to the field of biochemistry through his patents and work at Alexion Pharmaceuticals, Inc. highlight his role as an influential inventor. His innovative methods for producing recombinant proteins are paving the way for advancements in pharmaceutical manufacturing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…